[1]
M. U. Adehi, O. N. Nweze, N. I. Audi, and M. Bilkisu, “HETEROGENEITY IN CANCER RISK ASSOCIATED WITH ANTIHYPERTENSIVE DRUG USE: A META-ANALYSIS OF LOSARTAN AND AMLODIPINE”, Economics and Statistics Research Journal (ESRJ), vol. 16, no. 7, pp. 30–43, Jul. 2025.